Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-06-27
    E.g., 2018-06-27

Articles

Pages

1359 items
11:33 AM, May 25, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Aptinyx proposes $80M IPO

Neurology company Aptinyx Inc. (Evanston, Ill.) proposed to raise $80 million on May 23 in an IPO on NASDAQ underwritten by J.P. Morgan, Cowen, Leerink and BMO Capital Markets. The company expects data in 1H19 from...
12:09 PM, May 18, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

MeiraGTx proposes $86.3M IPO

MeiraGTx Holdings plc (New York, N.Y.) proposed to raise up to $86.3 million in an IPO on NASDAQ underwritten by BofA Merrill Lynch, Barclays, Evercore ISI and Chardan. The company is developing a portfolio of gene...
7:32 PM, May 17, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Kiniksa, Scholar Rock set IPO price ranges

Kiniksa Pharmaceuticals Ltd. (Hamilton, Bermuda) and Scholar Rock Holding Corp. (Cambridge, Mass.) each set price ranges on May 14 for their respective NASDAQ IPOs. Kiniksa now plans to sell 7 million shares at $17 to $19...
12:05 PM, May 11, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Stealth declines to comment on IPO rumors

Stealth BioTherapeutics Inc. declined to comment on a report that it is planning an IPO in Hong Kong as soon as this year. The company is developing first-generation targeted therapies to treat mitochondrial dysfunction associated...
11:29 AM, May 11, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Ascletis first to apply for HKEX biotech chapter

Ascletis Pharma Inc. (Hangzhou, China) plans to list on Hong Kong Exchanges and Clearing Ltd. (HKEX) in an IPO underwritten by Morgan Stanley, Goldman Sachs and China Merchants, according to a regulatory filing on May...
11:08 AM, May 11, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Provention plans IPO, reveals MacroGenics deal

Autoimmune and infectious disease company Provention Bio Inc. (Lebanon, N.J.) proposed on May 9 to raise up to $50 million in an IPO underwritten by MDB Capital Group. The company's pipeline includes several candidates in-licensed...
9:04 AM, May 04, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Ex-Synageva team planning Kiniksa IPO

Kiniksa Pharmaceuticals Ltd. (Hamilton, Bermuda) filed on April 27 to raise up to $100 million in an IPO on NASDAQ underwritten by Goldman Sachs, J.P. Morgan, JMP Securities and Wedbush PacGrow. Kiniksa Chairman and CEO Sanj...
12:18 PM, Apr 27, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Ping An Healthcare sets IPO range

Ping An Healthcare and Technology Co. Ltd. (Shanghai, China) amended its IPO on April 23 on the Hong Kong stock exchange and now plans to sell 160 million shares at HK$45.75-HK$54.80. The offering is being...
1:00 PM, Apr 20, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Microbiome company Evelo proposes $100M IPO

Microbiome company Evelo Biosciences Inc. (Cambridge, Mass.) proposed on April 13 to raise $100 million in an IPO on NASDAQ underwritten by Morgan Stanley, Cowen, BMO Capital Markets and JMP Securities. Evelo has a portfolio of...
1:00 PM, Apr 20, 2018  |  BC Week In Review | Financial News  |  Proposed Offerings

Panacea Venture proposes $150M fund

Kleiner Perkins Caufield & Byers (Menlo Park, Calif.) spinout Panacea Venture proposed to raise $150 million for Panacea Venture Healthcare Fund I, according to an April 3 SEC filing. Mi Hai and James Huang are...

Pages